Telemetry Investments, L.L.C. - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Telemetry Investments, L.L.C. ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$1,103,000
-33.4%
1,250,000
-37.5%
0.56%
-46.9%
Q4 2018$1,655,000
-51.0%
2,000,000
-50.0%
1.06%
-31.1%
Q3 2018$3,376,000
-0.2%
4,000,000
+14.3%
1.53%
+18.9%
Q2 2018$3,382,000
+86.0%
3,500,000
+75.0%
1.29%
+89.1%
Q1 2018$1,818,000
-52.3%
2,000,000
-55.6%
0.68%
-53.1%
Q4 2017$3,811,000
+5.6%
4,500,000
+12.5%
1.45%
+12.6%
Q3 2017$3,610,000
+5.2%
4,000,0000.0%1.29%
-20.1%
Q2 2017$3,433,000
-57.5%
4,000,000
-57.9%
1.62%
-55.4%
Q1 2017$8,075,000
+21.4%
9,500,000
+8.6%
3.62%
-3.6%
Q4 2016$6,650,000
+48.2%
8,750,000
+59.1%
3.76%
+33.6%
Q3 2016$4,486,000
+786.6%
5,500,000
+1000.0%
2.81%
+1133.8%
Q2 2015$506,000
-87.6%
500,000
-87.5%
0.23%
-89.9%
Q1 2015$4,095,000
-11.0%
4,000,0000.0%2.26%
-20.8%
Q4 2014$4,603,0004,000,0002.85%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
SYMPHONY ASSET MANAGEMENT LLC 23,872,000$18,748,0004.04%
PFM Health Sciences, LP 49,764,825$39,319,0001.16%
Partner Investment Management, L.P. 659,175$521,0000.89%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 40,000,000$31,402,000,0000.87%
Bruce & Co., Inc. 6,000,000$4,200,0000.87%
CANYON CAPITAL ADVISORS LLC 36,500,000$28,747,0000.62%
PenderFund Capital Management Ltd. 2,000,000$1,571,0000.53%
Shaolin Capital Management LLC 4,000,000$3,136,0000.48%
Castle Creek Arbitrage, LLC 2,310,000$1,815,0000.46%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$4,368,0000.27%
View complete list of ACORDA THERAPEUTICS INC shareholders